Published February 7, 2018
David Jacobs, PharmD ’11, clinical assistant professor, pharmacy practice, recently received the Buffalo Translational Consortium (BTC) Mentored Career Development Award for his project entitled, “A pilot study to evaluate objective assessment tools to improve medication management in chronic obstructive pulmonary disease.”
The BTC Mentored Career Development Award engages talented, motivated fellows and junior faculty scholars from different health science and clinical disciplines to join the clinical and translational science workforce to develop new treatments for diseases affecting our communities. The award will provide research training and mentoring, and Jacobs will receive support for research, tuition and travel costs for up to two years.
Jacobs' project will evaluate disease-specific health status assessment tools and physiological measurements in order to objectively evaluate clinical response to a new inhaled COPD maintenance therapy. “We believe these measurements and tools can be practical enough for daily clinical practice and combined to accurately assess clinical response to a new inhaled COPD medication,” he says.
Formed in 2009, the Buffalo Translational Consortium is a regional collaboration of the University at Buffalo health sciences schools, leading clinical institutions (UB|MD Practice Plan, Kaleida Health, Roswell Park Comprehensive Cancer Center, Erie County Medical Center and the Buffalo VA Medical Center), research institutes and community organizations. These partners share a commitment to perform research with a vision to improve health and reduce health disparities in the Western New York community.
The award is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health.